Rheumatology Practice Review, Issue 55

In this issue:

Living guideline for managing people with Behçets 2024
Targeted therapies in inflammatory arthritis and a history of cancer
Macrophage activation syndrome in adults and children
CD19-directed chimeric antigen receptor T-cell therapy for autoimmune diseases
Cardiovascular risk when initiating urate-lowering therapy with or without colchicine
Low versus high initial oral glucocorticoid dose for lupus nephritis
Development of quality indicators for hand osteoarthritis care
Paracetamol pack sizes reduced
Pharmaceutical Benefits Advisory Committee (PBAC) outcomes
FDA approves tocilizumab biosimilar
New patient platform for osteoarthritis
The Australian Rheumatology Association Annual Achievement Report
AI-assisted diagnosis for immunological and infectious diseases
Ribonucleoproteins promote female sex-biased autoimmunity